CLINICAL_TRIALS
trial_result
· 2015-09-03
Clinical Trial Update: OTO-104 for the Treatment of Meniere's Disease [Phase 2]
Summary
A Phase 2 clinical trial evaluating OTO-104 for the treatment of Meniere's disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Otonomy, Inc. | Conditions: Meniere's Disease | Phase 2 | Status: COMPLETED